DVAX Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of Dynavax Technologies Corporation is Fair to Shareholders

Core Viewpoint - The investigation by Halper Sadeh LLC focuses on the fairness of the acquisition of Dynavax Technologies Corporation by Sanofi at a price of $15.50 per share in cash, raising concerns about potential violations of federal securities laws and fiduciary duties to shareholders [1][2]. Group 1: Investigation Details - The investigation examines whether Dynavax and its board failed to secure the best possible consideration for shareholders [2]. - It questions if Sanofi is underpaying for Dynavax and whether all material information necessary for shareholders to assess the merger was disclosed [2]. Group 2: Legal Actions and Representation - Halper Sadeh LLC may seek increased consideration for Dynavax shareholders, additional disclosures, or other forms of relief related to the proposed transaction [3]. - The firm operates on a contingent fee basis, meaning shareholders would not incur out-of-pocket legal fees or expenses [3]. Group 3: Firm Background - Halper Sadeh LLC represents global investors affected by securities fraud and corporate misconduct, having successfully implemented corporate reforms and recovered millions for defrauded investors [4].